| | | | | |
ADAG Adagene Inc. American Depositary Shares | $3,3850 | -5,45% | $276,84M | $346,65K | |
OSG Octave Specialty Group, Inc. | $5,5400 | -5,14% | $276,38M | $375,86K | |
RILY BRC Group Holdings, Inc. Common Stock | $6,9300 | -2,12% | $275,73M | $355,40K | |
| $23,8000 | -2,74% | $275,58M | $188,38K | |
NHIV NewHold Investment Corp IV Class A Ordinary Shares | $10,1000 | +0,15% | $274,74M | $12,23K | |
| $4,0000 | -6,98% | $274,59M | $575,82K | |
TMCI Treace Medical Concepts, Inc. Common Stock | $4,0500 | +2,02% | $274,41M | $272,69K | |
| $10,8450 | -0,05% | $274,40M | $21,51K | |
LCTX Lineage Cell Therapeutics, Inc. | $1,0700 | -3,60% | $274,22M | $1,02M | |
SGHT Sight Sciences, Inc. Common Stock | $4,7050 | -6,46% | $274,22M | $237,33K | |
XSLL Xsolla SPAC 1 Class A Ordinary Shares | $9,9450 | +0,15% | $273,47M | $96,10K | |
OPRT Oportun Financial Corporation Common Stock | $5,2950 | -5,28% | $273,40M | $352,23K | |
ZH Zhihu Inc. American Depositary Shares, each representing three (3) Class A Ordinary Shares | $3,1300 | -0,32% | $272,52M | $181,42K | |
| $10,6500 | -0,65% | $272,46M | $48,62K | |
HVII Hennessy Capital Investment Corp. VII Ordinary Shares | $10,4750 | +0,00% | $272,46M | $10,62K | |
